DoD Gulf War Illness Clinical Trial Development Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD Gulf War Illness Clinical Trial Development Award

The GWIRP Clinical Trial Development Award (CTDA) mechanism was offered for the first time in FY11. The CTDA is intended to support planning activities necessary for the future conduct of a Phase II or Phase III clinical...

92
match
Award $0 Deadline 4659 days ago Location Alabama Type grant Level Federal Closed posted May 14, 2013
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$320,000.
  • Next deadline: September 18, 2013.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Award amount
$0
Deadline
4659 days ago
Sep 18, 2013
Total pool
$320k

About this opportunity

The GWIRP Clinical Trial Development Award (CTDA) mechanism was offered for the first time in FY11. The CTDA is intended to support planning activities necessary for the future conduct of a Phase II or Phase III clinical trial (or a trial of devices in Food and Drug Administration classes I-III), since these activities usually represent a significant expenditure of time and effort. The CTDA is a 1-year grant intended to allow investigators time to undertake preparatory activities and have the study rationale for a future clinical trial scientifically reviewed. The CTDA is not intended for the collection of preliminary data or the conduct of pilot studies to support the rationale for a future clinical trial. Applications must demonstrate that the rationale for the proposed clinical trial has already been clearly established, with appropriate supportive preliminary data. Clinical trial developmental activities allowed under a CTDA may include, but are not limited to: • Developing the clinical protocol and experimental design • Composing the research team and initiating collaborations necessary for the future clinical trial, and developing training procedures, as applicable • Investigating potential intellectual or material property issues, as applicable • Initiating access to an ill Gulf War veteran population and planning a recruitment strategy • Developing quality control/assurance procedures • Developing data collection/data management procedures • Developing a data analysis/statistical plan • Assessing potential issues regarding test article purity and formulation • Developing a safety monitoring plan • Determining a process for finalizing an FDA Investigational New Drug (IND)/ Investigational Device Exemption (IDE) application, if applicable • Developing a transition plan with associated resources and collaborations to continue to the next phase of research or commercialization • Conducting other preparatory activities needed to support the future clinical trial These activities do not involve the collection of data supported by traditional investigator-initiated research awards. Investigators interested in generating proof-of-principle data should consider the GWIRP’s Investigator-Initiated Research Award, aimed at basic research for GWI, or the Innovative Treatment Evaluation Award, which supports the initial evaluation of a treatment or intervention in small, early phase or pilot clinical trials (Phase II or I/II). For information about these award mechanisms, see http:/cdmrp.army.mil/funding.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID234614
PostedMay 14, 2013

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.